{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:11:09Z","timestamp":1776726669566,"version":"3.51.2"},"reference-count":28,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","pathologyjournal.rcpa.edu.au","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.pathol.2016.08.003","type":"journal-article","created":{"date-parts":[[2016,10,22]],"date-time":"2016-10-22T16:48:12Z","timestamp":1477154892000},"page":"660-665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Calretinin but not caveolin-1 correlates with tumour histology and survival in malignant mesothelioma"],"prefix":"10.1016","volume":"48","author":[{"given":"Bibhusal","family":"Thapa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzena","family":"Walkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmel","family":"Murone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khashayar","family":"Asadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddhartha","family":"Deb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Knight","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danny","family":"Liew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Neil","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2016.08.003_bib1","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1289\/ehp.1002845","article-title":"Global magnitude of reported and unreported mesothelioma","volume":"119","author":"Park","year":"2011","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.pathol.2016.08.003_bib2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev-publhealth-031811-124704","article-title":"The worldwide pandemic of asbestos-related diseases","volume":"34","author":"Stayner","year":"2013","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.pathol.2016.08.003_bib3","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2471\/BLT.11.086678","article-title":"Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008","volume":"89","author":"Delgermaa","year":"2011","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.pathol.2016.08.003_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2147\/TCRM.S1603","article-title":"Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesothelioma","volume":"4","author":"Goudar","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.pathol.2016.08.003_bib5","first-page":"2493","article-title":"Randomized trials of systemic medically-treated malignant mesothelioma: a systematic review","volume":"2502","author":"Blomberg","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.pathol.2016.08.003_bib6","first-page":"1","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial","volume":"6736","author":"Zalcman","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.pathol.2016.08.003_bib7","first-page":"10","article-title":"A\u00a0new standard for malignant pleural mesothelioma","volume":"6736","author":"Zauderer","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.pathol.2016.08.003_bib8","doi-asserted-by":"crossref","first-page":"9507","DOI":"10.1038\/srep09507","article-title":"Diagnostic accuracy of calretinin for malignant mesothelioma in serous effusions: a meta-analysis","volume":"5","author":"Li","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.pathol.2016.08.003_bib9","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.1365-2559.2011.04031.x","article-title":"Expression of calretinin by breast carcinoma and the potential for misdiagnosis of mesothelioma","volume":"59","author":"Powell","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2016.08.003_bib10","first-page":"559","article-title":"Expression of thrombomodulin, calretinin, cytokeratin 5\/6, D2-40 and WT-1 in a series of primary carcinomas of the lung: an immunohistochemical study in comparison with epithelioid pleural mesothelioma","volume":"100","author":"Comin","year":"2014","journal-title":"Tumori"},{"key":"10.1016\/j.pathol.2016.08.003_bib11","first-page":"929","article-title":"Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma","volume":"11","author":"Ord\u00f3\u00f1ez","year":"1998","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2016.08.003_bib12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2559.2009.03322.x","article-title":"Caveolin-1 is a novel immunohistochemical marker to differentiate epithelioid mesothelioma from lung adenocarcinoma","volume":"55","author":"Amatya","year":"2009","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2016.08.003_bib13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4161\/cbt.11.4.14101","article-title":"Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment","volume":"11","author":"Trimmer","year":"2014","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.pathol.2016.08.003_bib14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cell.2011.05.040","article-title":"Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis","volume":"146","author":"Goetz","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.pathol.2016.08.003_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2559.2009.03326.x","article-title":"Caveolin-1 expression in lung carcinoma varies according to tumour histotype and is acquired de novo in brain metastases","volume":"55","author":"Cassoni","year":"2009","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2016.08.003_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2490-11-25","article-title":"Caveolin 1 protein expression in renal cell carcinoma predicts survival","volume":"11","author":"Steffens","year":"2011","journal-title":"BMC Urol"},{"key":"10.1016\/j.pathol.2016.08.003_bib17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11010-014-2255-4","article-title":"Caveolin-1 regulates metastatic behaviors of anoikis resistant lung cancer cells","volume":"399","author":"Chanvorachote","year":"2015","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.pathol.2016.08.003_bib18","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1111\/j.1582-4934.2011.01364.x","article-title":"Caveolins in rhabdomyosarcoma","volume":"15","author":"Rossi","year":"2011","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.pathol.2016.08.003_bib19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.18632\/oncotarget.255","article-title":"Caveolin-1 in sarcomas: friend or foe?","volume":"2","author":"S\u00e1inz-Jaspeado","year":"2011","journal-title":"Oncotarget"},{"key":"10.1016\/j.pathol.2016.08.003_bib20","series-title":"The trial of differentiation grading of epithelioid mesothelioma with reference to its clinicopathological significance","author":"Yukio","year":"2010"},{"key":"10.1016\/j.pathol.2016.08.003_bib21","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1097\/JTO.0b013e31822a3740","article-title":"Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy","volume":"6","author":"Kao","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.pathol.2016.08.003_bib22","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1158\/1078-0432.CCR-10-2245","article-title":"High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy","volume":"16","author":"Kao","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2016.08.003_bib23","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1038\/bjc.2014.478","article-title":"Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales","volume":"111","author":"Linton","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pathol.2016.08.003_bib24","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1309\/AJCP0F6WYBXGVDHX","article-title":"Tumor\/stromal caveolin-1 expression patterns in pleural mesothelioma define a subgroup of the epithelial histotype with poorer prognosis","volume":"141","author":"Righi","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2016.08.003_bib25","doi-asserted-by":"crossref","first-page":"6803","DOI":"10.7314\/APJCP.2015.16.16.6803","article-title":"Caveolin-1 in breast cancer: single molecule regulation of multiple key signaling pathways","volume":"16","author":"Anwar","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.pathol.2016.08.003_bib26","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/path.4034","article-title":"Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts","volume":"227","author":"Simpkins","year":"2012","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.pathol.2016.08.003_bib27","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/modpathol.3800534","article-title":"Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity","volume":"19","author":"Yaziji","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2016.08.003_bib28","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/PAT.0b013e328342016c","article-title":"Validation of tissue microarray technology in malignant pleural mesothelioma","volume":"43","author":"Kao","year":"2011","journal-title":"Pathology"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516402928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516402928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T13:21:52Z","timestamp":1572614512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302516402928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0031302516402928"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2016.08.003","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calretinin but not caveolin-1 correlates with tumour histology and survival in malignant mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2016.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}